Summary Information:
Theravance Biopharma Inc. Ordinary Shares
NASDAQ:TBPH
email
admin@troach.net 		Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net
NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.
Theravance Biopharma Inc. Ordinary Shares
Exchange: NASDAQ
Symbol: TBPH
SEC CIK: 0001583107
Phone: 650-808-6000
UGLAND HOUSE, SOUTH CHURCH STREET
GEORGE TOWN, GRAND CAYMAN E9 KY1-1104

CEO: Rick Winningham
Price Quote by TradingView
Price when page updated: 10.585 Date: 2023-12-01
Company Website:
www.theravance.com

_Description: Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Its purpose is to create transformational medicines to improve the lives of patients suffering from serious illnesses. Its research is focused in the areas of inflammation and immunology.

IPO YEAR:

Sector:
Health Care
 Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
527110412.00
 Beta:
0.53106225386360
52 Week High:
22.74
 52 Week Low:
6.1
 52 Week Change:
-0.4124107633168589
Short Interest:

Short Date:

Shares Outstanding:
73698388
Dividend Rate:
0
 Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
N/A
Float:
0
return on Equity:
29.80%
 Consensus EPS:

Number Of Estimates:
EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
0
 Revenue:
$76.999M
 Gross Profit:
Cash:

Debt:

Institution Percent:
85.20%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
3.90%
Return on Assets:
-27.20%
 Return on Capital:

Profit Margin:
-
Price to Sales:
13.71
 Price To Book:
-
 Short Ratio:
8.41
PE Ratio:
0
 Employees:
359
 1Y Guesstimate
10.890:1.0:3


__The following are links to various summary and news pages for
__Theravance Biopharma Inc. Ordinary Shares [ TBPH ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX



Page design by: TRoach
Page Last Updated: 2023-12-01